Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 68

1.

PIRCHE-II Is Related to Graft Failure after Kidney Transplantation.

Geneugelijk K, Niemann M, Drylewicz J, van Zuilen AD, Joosten I, Allebes WA, van der Meer A, Hilbrands LB, Baas MC, Hack CE, van Reekum FE, Verhaar MC, Kamburova EG, Bots ML, Seelen MAJ, Sanders JS, Hepkema BG, Lambeck AJ, Bungener LB, Roozendaal C, Tilanus MGJ, Vanderlocht J, Voorter CE, Wieten L, van Duijnhoven EM, Gelens M, Christiaans MHL, van Ittersum FJ, Nurmohamed A, Lardy JNM, Swelsen W, van der Pant KA, van der Weerd NC, Ten Berge IJM, Bemelman FJ, Hoitsma A, van der Boog PJM, de Fijter JW, Betjes MGH, Heidt S, Roelen DL, Claas FH, Otten HG, Spierings E.

Front Immunol. 2018 Mar 5;9:321. doi: 10.3389/fimmu.2018.00321. eCollection 2018.

2.

Differential effects of donor-specific HLA antibodies in living versus deceased donor transplant.

Kamburova EG, Wisse BW, Joosten I, Allebes WA, van der Meer A, Hilbrands LB, Baas MC, Spierings E, Hack CE, van Reekum FE, van Zuilen AD, Verhaar MC, Bots ML, Drop ACAD, Plaisier L, Seelen MAJ, Sanders JSF, Hepkema BG, Lambeck AJA, Bungener LB, Roozendaal C, Tilanus MGJ, Voorter CE, Wieten L, van Duijnhoven EM, Gelens M, Christiaans MHL, van Ittersum FJ, Nurmohamed SA, Lardy NM, Swelsen W, van der Pant KA, van der Weerd NC, Ten Berge IJM, Bemelman FJ, Hoitsma A, van der Boog PJM, de Fijter JW, Betjes MGH, Heidt S, Roelen DL, Claas FH, Otten HG.

Am J Transplant. 2018 Feb 21. doi: 10.1111/ajt.14709. [Epub ahead of print]

PMID:
29464832
3.

Unique clinical conditions associated with different acinar regions of fibrosis in long-term surviving pediatric liver grafts.

Baas M, Gouw ASH, van den Heuvel MC, Hepkema BG, Peeters PMGJ, Verkade H, Scheenstra R.

Pediatr Transplant. 2017 Nov;21(7). doi: 10.1111/petr.12988. Epub 2017 Jun 18.

PMID:
28627016
4.

HLA expression and HLA type associations in relation to EBV status in Hispanic Hodgkin lymphoma patients.

Fletcher LB, Veenstra RN, Loo EY, Hwang AE, Siddiqi IN, Visser L, Hepkema BG, Nolte IM, van den Berg A, Cozen W, Diepstra A.

PLoS One. 2017 Mar 23;12(3):e0174457. doi: 10.1371/journal.pone.0174457. eCollection 2017.

5.

The increase of the global donor inventory is of limited benefit to patients of non-Northwestern European descent.

van Walraven SM, Brand A, Bakker JN, Heemskerk MB, Nillesen S, Bierings MB, Bungener LB, Hepkema BG, Lankester A, van der Meer A, Sintnicolaas K, Somers JA, Spierings E, Tilanus MG, Voorter CE, Cornelissen JJ, Oudshoorn M.

Haematologica. 2017 Jan;102(1):176-183. doi: 10.3324/haematol.2016.145730. Epub 2016 Aug 25.

6.

How can we reduce costs of solid-phase multiplex-bead assays used to determine anti-HLA antibodies?

Kamburova EG, Wisse BW, Joosten I, Allebes WA, van der Meer A, Hilbrands LB, Baas MC, Spierings E, Hack CE, van Reekum FE, van Zuilen AD, Verhaar M, Bots ML, Drop AC, Plaisier L, Seelen MA, Sanders JS, Hepkema BG, Lambeck AJ, Bungener LB, Roozendaal C, Tilanus MG, Vanderlocht J, Voorter CE, Wieten L, van Duijnhoven EM, Gelens M, Christiaans MH, van Ittersum FJ, Nurmohamed A, Lardy NM, Swelsen W, van der Pant KA, van der Weerd NC, Ten Berge IJ, Bemelman FJ, Hoitsma A, van der Boog PJ, de Fijter JW, Betjes MG, Heidt S, Roelen DL, Claas FH, Otten HG.

HLA. 2016 Sep;88(3):110-9. doi: 10.1111/tan.12860. Epub 2016 Aug 18.

PMID:
27534609
7.

Questionable expression of unstable DQ heterodimer containing HLA-DQA1*01:07.

Miyadera H, Bungener LB, Kusano S, Yokoyama S, Tokunaga K, Hepkema BG.

Tissue Antigens. 2015 Dec;86(6):413-8. doi: 10.1111/tan.12686. Epub 2015 Nov 9.

PMID:
26555242
8.

Toll-Like Receptor Family Polymorphisms Are Associated with Primary Renal Diseases but Not with Renal Outcomes Following Kidney Transplantation.

Dessing MC, Kers J, Damman J, Leuvenink HG, van Goor H, Hillebrands JL, Hepkema BG, Snieder H, van den Born J, de Borst MH, Bakker SJ, Navis GJ, Ploeg RJ, Florquin S, Seelen M, Leemans JC.

PLoS One. 2015 Oct 7;10(10):e0139769. doi: 10.1371/journal.pone.0139769. eCollection 2015.

9.

The PROCARE consortium: toward an improved allocation strategy for kidney allografts.

Otten HG, Joosten I, Allebes WA, van der Meer A, Hilbrands LB, Baas M, Spierings E, Hack CE, van Reekum F, van Zuilen AD, Verhaar MC, Bots ML, Seelen MA, Sanders JS, Hepkema BG, Lambeck AJ, Bungener LB, Roozendaal C, Tilanus MG, Vanderlocht J, Voorter CE, Wieten L, van Duijnhoven E, Gelens M, Christiaans M, van Ittersum F, Nurmohamed A, Lardy NM, Swelsen WT, van Donselaar-van der Pant KA, van der Weerd NC, Ten Berge IJ, Bemelman FJ, Hoitsma AJ, de Fijter JW, Betjes MG, Roelen DL, Claas FH.

Transpl Immunol. 2014 Oct;31(4):184-90. doi: 10.1016/j.trim.2014.09.008. Epub 2014 Oct 1.

PMID:
25258025
10.

Recipient's genetic R702W NOD2 variant is associated with an increased risk of bacterial infections after orthotopic liver transplantation.

Janse M, de Rooij BJ, van Hoek B, van den Berg AP, Porte RJ, Blokzijl H, Coenraad MJ, Hepkema BG, Schaapherder AF, Ringers J, Weersma RK, Verspaget HW.

PLoS One. 2013 Aug 19;8(8):e72617. doi: 10.1371/journal.pone.0072617. eCollection 2013.

11.

Variable EBV DNA load distributions and heterogeneous EBV mRNA expression patterns in the circulation of solid organ versus stem cell transplant recipients.

Greijer AE, Stevens SJ, Verkuijlen SA, Juwana H, Fleig SC, Verschuuren EA, Hepkema BG, Cornelissen JJ, Brooimans RA, Verdonck LF, Middeldorp JM.

Clin Dev Immunol. 2012;2012:543085. doi: 10.1155/2012/543085. Epub 2012 Dec 30.

12.

SLC22A2 is associated with tubular creatinine secretion and bias of estimated GFR in renal transplantation.

Reznichenko A, Sinkeler SJ, Snieder H, van den Born J, de Borst MH, Damman J, van Dijk MC, van Goor H, Hepkema BG, Hillebrands JL, Leuvenink HG, Niesing J, Bakker SJ, Seelen M, Navis G.

Physiol Genomics. 2013 Mar 18;45(6):201-9. doi: 10.1152/physiolgenomics.00087.2012. Epub 2013 Jan 22.

PMID:
23341218
13.

Successful lung transplantation in the presence of pre-existing donor-specific cytotoxic HLA Class II antibodies.

Lambeck AJ, Verschuuren EA, Bouwman I, Jongsma T, Roozendaal C, Bungener LB, van der Bij W, van den Berg AP, Erasmus ME, Timens W, Lems SP, Hepkema BG.

J Heart Lung Transplant. 2012 Dec;31(12):1301-6. doi: 10.1016/j.healun.2012.09.015. Epub 2012 Oct 15.

PMID:
23079068
14.

UMOD as a susceptibility gene for end-stage renal disease.

Reznichenko A, Böger CA, Snieder H, van den Born J, de Borst MH, Damman J, van Dijk MC, van Goor H, Hepkema BG, Hillebrands JL, Leuvenink HG, Niesing J, Bakker SJ, Seelen M, Navis G; REGaTTA (REnal GeneTics TrAnsplantation) Groningen group.

BMC Med Genet. 2012 Sep 5;13:78. doi: 10.1186/1471-2350-13-78.

15.

Meta-analysis identifies multiple loci associated with kidney function-related traits in east Asian populations.

Okada Y, Sim X, Go MJ, Wu JY, Gu D, Takeuchi F, Takahashi A, Maeda S, Tsunoda T, Chen P, Lim SC, Wong TY, Liu J, Young TL, Aung T, Seielstad M, Teo YY, Kim YJ, Lee JY, Han BG, Kang D, Chen CH, Tsai FJ, Chang LC, Fann SJ, Mei H, Rao DC, Hixson JE, Chen S, Katsuya T, Isono M, Ogihara T, Chambers JC, Zhang W, Kooner JS; KidneyGen Consortium; CKDGen Consortium, Albrecht E; GUGC consortium, Yamamoto K, Kubo M, Nakamura Y, Kamatani N, Kato N, He J, Chen YT, Cho YS, Tai ES, Tanaka T.

Nat Genet. 2012 Jul 15;44(8):904-9. doi: 10.1038/ng.2352.

16.

CUBN as a novel locus for end-stage renal disease: insights from renal transplantation.

Reznichenko A, Snieder H, van den Born J, de Borst MH, Damman J, van Dijk MC, van Goor H, Hepkema BG, Hillebrands JL, Leuvenink HG, Niesing J, Bakker SJ, Seelen M, Navis G; REGaTTA (REnal GeneTics TrAnsplantation) Groningen group.

PLoS One. 2012;7(5):e36512. doi: 10.1371/journal.pone.0036512. Epub 2012 May 4.

17.

Pretransplant HLA mistyping in diagnostic samples of acute myeloid leukemia patients due to acquired uniparental disomy.

Dubois V, Sloan-Béna F, Cesbron A, Hepkema BG, Gagne K, Gimelli S, Heim D, Tichelli A, Delaunay J, Drouet M, Jendly S, Villard J, Tiercy JM.

Leukemia. 2012 Sep;26(9):2079-85. doi: 10.1038/leu.2012.68. Epub 2012 Mar 14.

PMID:
22488219
18.

CCR5Δ32 genotype leads to a Th2 type directed immune response in ESRD patients.

Muntinghe FL, Abdulahad WH, Huitema MG, Damman J, Seelen MA, Lems SP, Hepkema BG, Navis G, Westra J.

PLoS One. 2012;7(2):e31257. doi: 10.1371/journal.pone.0031257. Epub 2012 Feb 13.

19.

Association of complement C3 gene variants with renal transplant outcome of deceased cardiac dead donor kidneys.

Damman J, Daha MR, Leuvenink HG, van Goor H, Hillebrands JL, Dijk MC, Hepkema BG, Snieder H, Born Jv, de Borst MH, Bakker SJ, Navis GJ, Ploeg RJ, Seelen MA.

Am J Transplant. 2012 Mar;12(3):660-8. doi: 10.1111/j.1600-6143.2011.03880.x. Epub 2011 Dec 17.

20.

Lectin complement pathway gene profile of the donor and recipient does not influence graft outcome after kidney transplantation.

Damman J, Kok JL, Snieder H, Leuvenink HG, van Goor H, Hillebrands JL, van Dijk MC, Hepkema BG, Reznichenko A, van den Born J, de Borst MH, Bakker SJ, Navis GJ, Ploeg RJ, Seelen MA.

Mol Immunol. 2012 Feb;50(1-2):1-8. doi: 10.1016/j.molimm.2011.11.009. Epub 2011 Dec 15.

PMID:
22173059

Supplemental Content

Loading ...
Support Center